These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 19560497)

  • 21. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery.
    Shahin M; Lavasanifar A
    Int J Pharm; 2010 Apr; 389(1-2):213-22. PubMed ID: 20080163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
    Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
    Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preparation of paclitaxel-loaded chitosan polymeric micelles and influence of surface charges on their tissue biodistribution in mice].
    Huo MR; Zhou JP; Wei Y; Lü L
    Yao Xue Xue Bao; 2006 Sep; 41(9):867-72. PubMed ID: 17111835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier].
    Gong JL; Wang SM; Hu XG; Cao MM; Zhang JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2183-6. PubMed ID: 19114352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conjugated chitosan as a novel platform for oral delivery of paclitaxel.
    Lee E; Lee J; Lee IH; Yu M; Kim H; Chae SY; Jon S
    J Med Chem; 2008 Oct; 51(20):6442-9. PubMed ID: 18826299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
    Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring.
    Kim K; Kim JH; Park H; Kim YS; Park K; Nam H; Lee S; Park JH; Park RW; Kim IS; Choi K; Kim SY; Park K; Kwon IC
    J Control Release; 2010 Sep; 146(2):219-27. PubMed ID: 20403397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
    Shimada T; Ueda M; Jinno H; Chiba N; Wada M; Watanabe J; Ishihara K; Kitagawa Y
    Anticancer Res; 2009 Apr; 29(4):1009-14. PubMed ID: 19414339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy.
    Yoon HY; Saravanakumar G; Heo R; Choi SH; Song IC; Han MH; Kim K; Park JH; Choi K; Kwon IC; Park K
    J Control Release; 2012 Jun; 160(3):692-8. PubMed ID: 22543013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug.
    Jang MK; Jeong YI; Nah JW
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):530-6. PubMed ID: 20801624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
    J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release.
    Park JS; Han TH; Lee KY; Han SS; Hwang JJ; Moon DH; Kim SY; Cho YW
    J Control Release; 2006 Sep; 115(1):37-45. PubMed ID: 16935380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.
    Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S
    J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation.
    Yu J; Liu Y; Zhang L; Zhao J; Ren J; Zhang L; Jin Y
    J Biomater Sci Polym Ed; 2015; 26(18):1475-89. PubMed ID: 26489688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
    Letchford K; Liggins R; Wasan KM; Burt H
    Eur J Pharm Biopharm; 2009 Feb; 71(2):196-206. PubMed ID: 18762253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice.
    Lee SJ; Park K; Oh YK; Kwon SH; Her S; Kim IS; Choi K; Lee SJ; Kim H; Lee SG; Kim K; Kwon IC
    Biomaterials; 2009 May; 30(15):2929-39. PubMed ID: 19254811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.
    Yoshizawa Y; Kono Y; Ogawara K; Kimura T; Higaki K
    Int J Pharm; 2011 Jun; 412(1-2):132-41. PubMed ID: 21507344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.
    Nam T; Park S; Lee SY; Park K; Choi K; Song IC; Han MH; Leary JJ; Yuk SA; Kwon IC; Kim K; Jeong SY
    Bioconjug Chem; 2010 Apr; 21(4):578-82. PubMed ID: 20201550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.